A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features
Clinical trial NCT06999941 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06999941
- Sponsor
- Xi Tan
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2025-04-24
- Primary completion
- 2026-08-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.